At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Investigation of the Effects of Glycaemic Optimisation Before Gastric Bypass Surgery on the Glycaemic Remission and Microvascular Complication Rates of Type 2 Diabetes Mellitus
In Brief
A clinical study evaluating gastric bypass for Type 2 Diabetes. Completed, enrolled 41 participants across 2 sites.
Detailed Summary
Metabolic surgery such as gastric bypass, gastric banding or sleeve gastrectomy operations can cause rapid and uncontrolled reductions in blood glucose. There is limited information on whether: * metabolic surgery is superior to modern medical care for glycaemic control and type 2 diabetes remission. * metabolic surgery is safe for microvascular complications of Type 2 diabetes * good glycaemic control pre surgery has any effects on the long term glycaemia and complications of type 2 diabetes. This study aims to assess: 1. whether metabolic surgery is better for diabetes control compared to medical treatment. 2. whether metabolic surgery is safe for eye, nerve and kidney complications. 3. whether good sugar control before metabolic surgery improves the long term effects of sugar control and microvascular complications.
Study Details
Timeline
Interventions
Optimise glucose control within 3 months before operation